Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and carboplatin

fluorodeoxyglucose f18 has been researched along with carboplatin in 60 studies

Research

Studies (60)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (20.00)29.6817
2010's41 (68.33)24.3611
2020's7 (11.67)2.80

Authors

AuthorsStudies
Boyd, JH; Collins, BT; Dunleavy, T; Dunphy, FR; Fletcher, JW; Hollenbeak, C; Kim, H; Lowe, VJ; Martin, D; Stack, BC1
Baumann, M; Fleckenstein, J; Hellwig, D; Kirsch, CM; Nestle, U; Rübe, C; Ukena, D; Walter, K1
Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y1
Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y; Yoshida, M1
Gillessen, S; Joerger, M; Klaeser, B; Kluckert, JT; Schmid, HP; Warzinek, T1
Ajani, JA; Bresalier, R; Correa, AM; Erasmus, JJ; Komaki, R; Macapinlac, H; Maish, M; Munden, RF; Putnam, JB; Rice, D; Roth, JA; Smythe, WR; Swisher, SG; Vaporciyan, AA; Walsh, GL; Wu, TT1
Baum, RP; Bonnet, R; Junker, K; Müller, KM; Schmücking, M1
Handa, M; Hirai, S; Ihaya, A; Imamura, Y; Kawabe, M; Morioka, K; Sasaki, K; Shinoda, T; Tanabe, S; Tanaka, K; Uesaka, T; Yamada, N1
Boellaard, R; Crezee, H; Hoekstra, OS; Hulshof, MC; Omloo, JM; Sloof, GW; ten Kate, FJ; van Lanschot, JJ; Vervenne, WL; Westerterp, M1
Bares, R; Budach, W; Dittmann, H; Eschmann, SM; Friedel, G; Hehr, T; Langen, HJ; Paulsen, F; Reimold, M1
Hanna, WT; Hubner, KF; Long, MJ; Nahmias, C; Townsend, DW; Wahl, LM1
De Grève, J; De Mey, J; Decoster, L; Everaert, H; Meysman, M; Neyns, B; Nieboer, K; Schallier, D1
Schaefer, NG; Seifert, B; Soyka, JD; Stahel, RA; Steinert, HC; Veit-Haibach, P1
Boersma, L; Bootsma, G; De Ruysscher, D; Dehing-Oberije, C; Dingemans, AM; Geraedts, W; Hochstenbag, M; Lambin, P; Oellers, M; Pitz, C; Rhami, A; Simons, J; Snoep, G; Teule, J; Thimister, W; van Loon, J; Wanders, R1
Agool, A; Brouwers, AH; Dijkstra, PU; Krabbe, CA; Phan, TT; Pruim, J; Roodenburg, JL; Scholtens, AM1
Ball, DL; Binns, D; Ding, Z; Herschtal, A; Hicks, RJ; Hogg, A; Mac Manus, MP1
Araki, O; Chida, M; Fukushima, Y; Honma, K; Inoue, T; Tamura, M; Tatewaki, M; Umezu, H1
Bernardi, A; Castellucci, P; D'Errico Grigioni, A; De Iaco, P; Fanti, S; Lopci, E; Martoni, AA; Musto, A; Quercia, S; Ricci Maccarini, L; Rosati, M; Zamagni, C1
Chang, AJ; Grigsby, PW; Richardson, S; Schwarz, JK1
Bergman, JJ; Boellaard, R; Bonenkamp, HJ; Bossuyt, PM; Busch, OR; Cuesta, MA; Hoekstra, OS; Hulshof, MC; Nieuwenhuijzen, GA; Omloo, JM; Plukker, JT; Pruim, J; Sloof, GW; Ten Kate, FJ; Tilanus, HW; van Berge Henegouwen, MI; van Dekken, H; van der Gaast, A; van Heijl, M; van Lanschot, JJ1
Albarghach, N; Corcos, L; Hatt, M; Le Rest, CC; Metges, JP; Pradier, O; Tixier, F; Visvikis, D1
Beadsmoore, C; Geropantas, K; Loo, SW; Martin, WM; Montgomery, PQ; Roques, TW1
Wang, SX; Wu, YL; Xu, CR; Yan, HH; Yang, JJ; Zhong, WZ1
Mason, DP1
Fujii, K; Ichiyasu, H; Kohrogi, H; Saeki, S; Saita, N; Sakata, S; Sasaki, J; Sato, R1
Anai, S; Harada, T; Ijichi, K; Koga, T; Kubo, N; Nakanishi, Y; Otsubo, K; Takayama, K; Yoneshima, Y1
Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM1
Demura, Y; Kimura, H; Morikawa, M; Okazawa, H; Tsuchida, T; Umeda, Y1
Capitain, O; Cellier, P; Denis, F; Girault, S; Hamy, A; Mahé, MA; Mesgouez-Nebout, N; Paumier, A; Poirier, AL; Rousseau, D1
Levra, MG; Novello, S; Pelosi, E; Scagliotti, GV; Solitro, F; Vavalà, T; Veltri, A1
Gilhuijs, KG; Koolen, BB; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; Vincent, AD; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J1
Alavi, A; Bradley, JD; Cho, KH; DeNittis, A; Duan, F; Gorelick, JJ; Johnson, DW; Kim, SK; Komaki, R; Macapinlac, H; Machtay, M; Munden, R; Neumann, DR; Reddin, JS; Sherwin, N; Siegel, BA; Snyder, BS; Videtic, G; Wilf, LH1
Crivellaro, C; Cuzzocrea, M; Dell'Anna, T; Dolci, C; Fruscio, R; Guerra, L; Messa, C; Milani, R; Signorelli, M; Sina, F1
Björkling, F; Erichsen, KD; Højgaard, L; Jensen, PB; Kjær, A; Madsen, J; Munk Jensen, M; Sehested, M1
Ando, M; Asami, K; Atagi, S; Ishii, M; Kanazu, M; Kawaguchi, T; Kubo, A; Kusunoki, Y; Maruyama, K; Matsuda, Y; Minomo, S; Ogawa, Y; Takada, M; Uehira, K1
Chan, WW; Choy, TS; Ho, PP; Khong, PL; Kwong, DL; Lam, KO; Lee, EY; Lee, VH; Leung, DK; Leung, TW1
Cho, J; Choi, NC; Sharp, GC; Shusharina, N1
Hasegawa, M; Imai, Y; Kirita, T; Kuniyasu, H; Kurihara, M; Sasahira, T; Shimomura, H; Shirone, N; Tamaki, S; Yamakawa, N; Yamanaka, Y1
Boughey, JC; Carey, LA; Carpenter, J; Connolly, RM; Davidson, NE; Fetting, JH; Gabrielson, E; Goetz, MP; Jacobs, LK; Jeter, SC; Khouri, N; Leal, JP; Mhlanga, J; Miller, RS; O, JH; Powers, P; Sideras, K; Stearns, V; Storniolo, AM; Wahl, RL; Walsh, B; Watkins, S; Wolff, AC; Zhang, Z; Zhou, XC; Zorzi, J1
Advani, RH; Gascoyne, R; Habermann, TM; Hong, F; Horning, SJ; Kahl, BS; Li, H; Quon, A; Ranheim, EA; Swinnen, LJ1
Dank, M; Györke, T; Kajáry, K; Kulka, J; Lengyel, Z; Molnár, BÁ; Szentmártoni, G; Tőkés, AM; Tőkés, T; Torgyík, L1
Prestwich, RJ; Ramasamy, S; Scarsbrook, AF; Sen, M; Slevin, F; Subesinghe, M1
Chino, Y; Fujita, Y; Kiyono, Y; Kurokawa, T; Okazawa, H; Tsujikawa, T; Yamamoto, M; Yoshida, Y1
Biner Uslu, I; Dikmen, A; Erdoğan, Y; Yilmaz Demirci, N; Yılmaz, A; Yilmaz, Ü1
Boellaard, R; de Jong, EE; Dingemans, AC; Groen, HJ; Hoekstra, OS; Lambin, P; Leijenaar, RT; Smit, EF; Troost, EG; van der Noort, V; van Elmpt, W1
Anile, G; Banna, GL; Calcara, G; Castaing, M; Fraggetta, F; Gieri, S; Ippolito, M; Marletta, F; Nicolosi, M; Patanè, D; Russo, G; Spina, R; Stefano, A; Strano, S; Vigneri, P1
Elkhuizen, PH; Koolen, BB; Rodenhuis, S; Rutgers, EJ; Stokkel, MP; Teixeira, SC; Valdés Olmos, RA; van der Noort, V; Vrancken Peeters, MT1
Inoue, T; Ishikawa, T; Kaneta, T; Narui, K; Noritake, M; Sakamaki, K; Sugae, S1
Butcher, B; Chong, G; Cull, G; Fay, K; Filshie, R; Gandhi, MK; Gill, D; Grigg, A; Hahn, U; Hertzberg, M; Hicks, RJ; Ho, SJ; Hofman, MS; Johnston, A; Kannourakis, G; Lewis, ID; Milliken, S; Renwick, W; Seymour, JF; Taper, J; Trotman, J; Warburton, P; Watson, AM; Wirth, A1
Allinson, K; Candy, N; Carr, O; McMillen, J; Trivedi, R; Young, A1
Bi, N; Cease, KB; Frey, KA; Gross, M; Hassan, KA; Hayman, J; Kalemkerian, GP; Kong, FM; Lawrence, TS; Matuszak, M; Orringer, M; Ramnath, N; Ritter, T; Schipper, M; Ten Haken, RK; Wang, W1
Giroulet, F; Pomoni, A; Prior, J; Tabotta, F1
Bennink, RJ; Bijlsma, MF; Creemers, A; Ebbing, EA; Hulshof, MCCM; Jibodh, RA; Krishnadath, KK; Medema, JP; Meijer, SL; Punt, CJA; Steins, A; van Delden, OM; van der Zalm, AP; van Laarhoven, HWM; Waasdorp, C1
Bordenave, L; Bouabdallah, K; Hindié, E; Mesguich, C; Milpied, N; Roch, A; Tlili, G1
Agaimy, A; Fietkau, R; Haderlein, M; Hecht, M; Iro, H; Kitzsteiner, C; Kuwert, T; Müller, S; Schmidt, D; Semrau, S; Traxdorf, M1
Bastien, C; Campitiello, M; Gehin, W; Hennequin, L; Jaud, C; Longo, R; Plastino, F; Rozzi, A1
Bekaii-Saab, T; Boffa, DJ; Frankel, WL; Fruth, B; Goodman, KA; Hall, NC; Ilson, DH; Janjigian, YY; Meyerhardt, JA; Meyers, MO; Mitchell, K; Niedzwiecki, D; Noonan, A; O'Reilly, EM; Ou, FS; Thurmes, PJ; Twohy, E; Venook, AP1
Abraham, C; Barthelemy, P; Bompas, E; Chevreau, C; Culine, S; Fizazi, K; Fléchon, A; Geoffrois, L; Gravis, G; Grimaldi, S; Gross-Goupil, M; Helissey, C; Lacourtoisie, SA; Ladoire, S; Laguerre, B; Loriot, Y; Mahammedi, H; Massard, C; Texier, M; Thiery-Vuillemin, A1
Allen, PB; Bazzi, LA; Bryan, LJ; Casulo, C; Chmiel, JS; Dillehay, GL; Gordon, LI; Kane, KL; Karmali, R; Mehta, J; Palmer, BA; Pro, B; Savas, H; Smith, SE; Winter, JN1
Bowen, SR; Gates, EDH; Hippe, DS; Vesselle, HJ; Zeng, J1

Reviews

2 review(s) available for fluorodeoxyglucose f18 and carboplatin

ArticleYear
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    The Annals of thoracic surgery, 2004, Volume: 78, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Irinotecan; Life Tables; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Preoperative Care; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Taxoids; Tomography, X-Ray Computed; Treatment Outcome

2004
The role of surgery for locally advanced non-small cell lung cancer.
    Cleveland Clinic journal of medicine, 2012, Volume: 79 Electronic Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Quinazolines; Survival Rate; Tomography, X-Ray Computed

2012

Trials

20 trial(s) available for fluorodeoxyglucose f18 and carboplatin

ArticleYear
Surveillance for recurrent head and neck cancer using positron emission tomography.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Tomography, Emission-Computed

2000
FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome

2003
Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Doxorubicin; False Negative Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Sensitivity and Specificity; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Treatment Outcome

2003
[Correlation of histologic results with PET findings for tumor regression and survival in locally advanced non-small cell lung cancer after neoadjuvant treatment].
    Der Pathologe, 2005, Volume: 26, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome

2005
Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Taxoids; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2007
Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC).
    Lung cancer (Amsterdam, Netherlands), 2008, Volume: 62, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Deoxycytidine; Female; Fluorodeoxyglucose F18; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed; Treatment Outcome

2008
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer.
    Annals of surgery, 2011, Volume: 253, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Paclitaxel; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; ROC Curve; Treatment Outcome

2011
Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography.
    Journal of magnetic resonance imaging : JMRI, 2013, Volume: 38, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diffusion Magnetic Resonance Imaging; Early Detection of Cancer; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome

2013
Early response to chemotherapy in patients with non-small-cell lung cancer assessed by [18F]-fluoro-deoxy-D-glucose positron emission tomography and computed tomography.
    Clinical lung cancer, 2013, Volume: 14, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Niacinamide; Paclitaxel; Phenylurea Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sorafenib; Tomography, X-Ray Computed

2013
Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Oct-20, Volume: 31, Issue:30

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Outcome

2013
Early pharmacodynamic assessment using ¹⁸F-fluorodeoxyglucose positron-emission tomography on molecular targeted therapy and cytotoxic chemotherapy for clinical outcome prediction.
    Clinical lung cancer, 2014, Volume: 15, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Paclitaxel; Positron-Emission Tomography; Quinazolines; Radiopharmaceuticals; Treatment Outcome

2014
TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Biomarkers, Tumor; Breast Neoplasms; Carboplatin; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Positron-Emission Tomography; Preoperative Period; Receptor, ErbB-2; Safety; Time Factors; Treatment Outcome; Young Adult

2015
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).
    British journal of haematology, 2015, Volume: 170, Issue:1

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prospective Studies; Rituximab; Vincristine; Young Adult

2015
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches.
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Netherlands; Nitroglycerin; Paclitaxel; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Vasodilator Agents

2017
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
    Haematologica, 2017, Volume: 102, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Positron-Emission Tomography; Prednisone; Retreatment; Rituximab; Treatment Outcome; Vincristine; Young Adult

2017
Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.
    JAMA oncology, 2017, Oct-01, Volume: 3, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiotherapy, Conformal; Survival Analysis; Treatment Outcome

2017
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 09-01, Volume: 39, Issue:25

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Oxaliplatin; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Young Adult

2021
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    European urology, 2022, Volume: 82, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Treatment Outcome

2022
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial.
    JAMA oncology, 2023, 05-01, Volume: 9, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Ifosfamide; Male; Positron Emission Tomography Computed Tomography; Salvage Therapy

2023
Independent association of metabolic tumor response on FDG-PET with pulmonary toxicity following risk-adaptive chemoradiation for unresectable non-small cell lung cancer: Inherent radiosensitivity or immune response?
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2023, Volume: 185

    Topics: Carboplatin; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Immunity; Lung Neoplasms; Paclitaxel; Pneumonia; Positron Emission Tomography Computed Tomography; Radiation Pneumonitis; Radiation Tolerance

2023

Other Studies

38 other study(ies) available for fluorodeoxyglucose f18 and carboplatin

ArticleYear
Comparison of early pulmonary changes in 18FDG-PET and CT after combined radiochemotherapy for advanced non-small-cell lung cancer: a study in 15 patients.
    Frontiers of radiation therapy and oncology, 2002, Volume: 37

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Radiation Pneumonitis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vinblastine; Vinorelbine

2002
Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer.
    Urology, 2004, Volume: 63, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Penile Neoplasms; Penis; Remission Induction; Survival Analysis; Tomography, Emission-Computed

2004
[Yolk sac tumor of the anterior mediastinum and pulmonary metastases; report of a case].
    Kyobu geka. The Japanese journal of thoracic surgery, 2005, Volume: 58, Issue:12

    Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Endodermal Sinus Tumor; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lung Neoplasms; Mediastinal Neoplasms; Positron-Emission Tomography; Superior Vena Cava Syndrome

2005
Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2006, Volume: 22, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiotherapy; Sensitivity and Specificity; Treatment Outcome

2006
Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2007, Volume: 55, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis

2007
Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma.
    Lung cancer (Amsterdam, Netherlands), 2010, Volume: 67, Issue:3

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Female; Fluorodeoxyglucose F18; Glutamates; Glycolysis; Guanine; Humans; Male; Mesothelioma; Palliative Care; Pemetrexed; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Treatment Outcome

2010
Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
    International journal of radiation oncology, biology, physics, 2010, Jun-01, Volume: 77, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Irradiation; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Small Cell Lung Carcinoma; Survival Analysis; Tomography, X-Ray Computed

2010
18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2010, Volume: 68, Issue:1

    Topics: Carboplatin; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Nuclear Medicine; Observer Variation; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity

2010
Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.
    International journal of radiation oncology, biology, physics, 2011, Aug-01, Volume: 80, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lung; Lung Neoplasms; Lymphatic Irradiation; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Radiation Pneumonitis; Radiopharmaceuticals; Radiotherapy Dosage; Time Factors

2011
Sarcoidosis development during induction chemotherapy for lung cancer mimicked progressive disease.
    General thoracic and cardiovascular surgery, 2010, Volume: 58, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed

2010
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:1

    Topics: Adult; Aged; Carboplatin; Chemotherapy, Adjuvant; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed

2011
Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer.
    International journal of radiation oncology, biology, physics, 2012, Jan-01, Volume: 82, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anatomic Landmarks; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Feasibility Studies; Female; Femur Head; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Intestines; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvic Bones; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rectum; Tomography, Spiral Computed; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder; Uterine Cervical Neoplasms

2012
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome

2011
Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2011, Volume: 23, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed

2011
Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients wi
    Nuclear medicine communications, 2011, Volume: 32, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Organoplatinum Compounds; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, Spiral Computed; Tomography, X-Ray Computed; Treatment Outcome

2011
FDG-PET and chemotherapy for successful diagnosis and treatment of cardiac metastasis from non-small cell lung cancer.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Electrocardiography; Female; Fluorodeoxyglucose F18; Glutamates; Guanine; Heart Neoplasms; Humans; Lung Neoplasms; Middle Aged; Pemetrexed; Positron-Emission Tomography; Radiopharmaceuticals

2012
Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:17

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Neoplasm Staging; Neoplasms, Muscle Tissue; Paclitaxel; Positron-Emission Tomography; Radiography; Thoracic Vertebrae; Treatment Outcome

2012
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Nov-10, Volume: 30, Issue:32

    Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms

2012
[Esophageal cancer: outcome according to therapeutic strategy].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2013, Volume: 17, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2013
Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla.
    Annals of surgical oncology, 2013, Volume: 20, Issue:7

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Axilla; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; ROC Curve; Trastuzumab

2013
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer.
    Gynecologic oncology, 2013, Volume: 131, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome

2013
Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PET.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Fluorodeoxyglucose F18; Heterografts; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Time Factors

2013
Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.
    American journal of clinical oncology, 2016, Volume: 39, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Survival Rate

2016
Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer.
    International journal of radiation oncology, biology, physics, 2014, May-01, Volume: 89, Issue:1

    Topics: Aged; Aged, 80 and over; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Conformal; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed

2014
[18F]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma.
    International journal of clinical oncology, 2015, Volume: 20, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ki-67 Antigen; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals

2015
Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study.
    Croatian medical journal, 2015, Volume: 56, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cross-Sectional Studies; Docetaxel; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Sensitivity and Specificity; Taxoids; Tomography, X-Ray Computed; Trastuzumab

2015
Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
    The British journal of radiology, 2015, Volume: 88, Issue:1052

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome

2015
Metabolic tumor burden predicts prognosis of ovarian cancer patients who receive platinum-based adjuvant chemotherapy.
    Cancer science, 2016, Volume: 107, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Carboplatin; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Ovarian Neoplasms; Paclitaxel; Positron-Emission Tomography; Prognosis; Tumor Burden

2016
Prognostic significance of standardised uptake value (SUV
    European journal of cancer care, 2017, Volume: 26, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Retrospective Studies; Serum Albumin; Small Cell Lung Carcinoma

2017
Predictive and Prognostic Value of Early Disease Progression by PET Evaluation in Advanced Non-Small Cell Lung Cancer.
    Oncology, 2017, Volume: 92, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed

2017
PET/CT with
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2017, Volume: 43, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Trastuzumab; Young Adult

2017
Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:3

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Taxoids; Trastuzumab; Treatment Outcome; Whole Body Imaging

2017
Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath.
    World neurosurgery, 2017, Volume: 104

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Etoposide; Female; Femoral Nerve; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Nerve Sheath Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2017
Primary parotid Merkel cell carcinoma: a first imagery and treatment response assessment by 18F-FDG PET.
    BMJ case reports, 2019, Mar-09, Volume: 12, Issue:3

    Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Etoposide; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2019
Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma.
    International journal of cancer, 2019, 11-15, Volume: 145, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Chemoradiotherapy; Disease Progression; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Esophageal Mucosa; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Positron-Emission Tomography; Primary Cell Culture; Progression-Free Survival; Signal Transduction; Transforming Growth Factor beta; Treatment Outcome; Xenograft Model Antitumor Assays

2019
Prognostic utility of pre-transplantation [
    British journal of haematology, 2020, Volume: 188, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Dexamethasone; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Rituximab; Salvage Therapy

2020
Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1).
    Oral oncology, 2020, Volume: 100

    Topics: Adult; Aged; Carboplatin; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Patient Selection; Positron Emission Tomography Computed Tomography; Retrospective Studies; Surgical Procedures, Operative; Survival Analysis; Treatment Outcome

2020
Renal Metastases from a Nasal Cavity Mixed Squamous Cell and Adenoid Cystic Carcinoma: A Case Report.
    The American journal of case reports, 2020, Jan-08, Volume: 21

    Topics: Carboplatin; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Cetuximab; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Nasal Cavity; Nose Neoplasms; Paclitaxel; Palliative Care; Positron-Emission Tomography; Rare Diseases

2020